Oncology companies

Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases.

Inspyr Therapeutics (formerly known as GenSpera) is a development-stage pharmaceutical company focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature.

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.

Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment.

Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.

Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs.

Mainz BioMed is a molecular genetics cancer diagnostic company that manufactures in-vitro diagnostic (IVD) tests.

MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.

Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.

Tyra Biosciences is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance.